Filing Details
- Accession Number:
- 0000899243-17-025519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-07 17:04:21
- Reporting Period:
- 2017-11-06
- Accepted Time:
- 2017-11-07 17:04:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
10456 | Baxter International Inc | NYSE: BAX | Surgical & Medical Instruments & Apparatus (3841) | 360781620 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1040273 | Third Point Llc | 390 Park Avenue New York NY 10022 | Yes | No | No | Yes | |
1300345 | S Daniel Loeb | C/O Third Point Llc 390 Park Avenue New York NY 10022 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $1.00 Par Value ("Common Stock") | Disposition | 2017-11-06 | 5,000,000 | $64.23 | 36,001,790 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- Except as otherwise noted herein, the securities disclosed in this Form 4 are owned by certain funds (the "Funds") managed by Third Point LLC ("Third Point"). Daniel S. Loeb is the Chief Executive Officer of Third Point. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, Third Point and Mr. Loeb may be deemed to be the beneficial owners of the securities beneficially owned by the Funds. Third Point and Mr. Loeb hereby disclaim beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein.